Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7) Article

Industry Collaboration International Collaboration

cited authors

  • Pratley, Richard E.; Emerson, Scott S.; Franek, Edward; Gilbert, Matthew P.; Marso, Steven P.; McGuire, Darren K.; Pieber, Thomas R.; Zinman, Bernard; Hansen, Charlotte T.; Hansen, Melissa V.; Mark, Thomas; Moses, Alan C.; Buse, John B.; DEVOTE Study Grp

Publication Date

  • July 1, 2019

webpage

published in

category

keywords

  • basal insulin
  • cardiovascular disease
  • hypoglycaemia
  • type 2 diabetes

start page

  • 1625

end page

  • 1633

volume

  • 21

issue

  • 7